These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19694833)

  • 1. HER-2/Neu overexpression is a rare event in peri-ampullary cancer: assessment using the HercepTest.
    Aloysius MM; Lobo DN; Rowlands BJ; Madhusudan S; Ilyas M; Zaitoun AM
    Histopathology; 2009 Aug; 55(2):236-7. PubMed ID: 19694833
    [No Abstract]   [Full Text] [Related]  

  • 2. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
    Dancer J; Takei H; Ro JY; Lowery-Nordberg M
    Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification and overexpression of HER-2/neu in invasive ductal carcinomas of the pancreas and pancreatic intraepithelial neoplasms and the relationship to the expression of p21(WAF1/CIP1).
    Hermanová M; Lukás Z; Nenutil R; Brázdil J; Kroupová I; Kren L; Pazourková M; Růzicka M; Díte P
    Neoplasma; 2004; 51(2):77-83. PubMed ID: 15190415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma.
    Safran H; Steinhoff M; Mangray S; Rathore R; King TC; Chai L; Berzein K; Moore T; Iannitti D; Reiss P; Pasquariello T; Akerman P; Quirk D; Mass R; Goldstein L; Tantravahi U
    Am J Clin Oncol; 2001 Oct; 24(5):496-9. PubMed ID: 11586103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HER-family gene amplification and expression in resected pancreatic cancer.
    te Velde EA; Franke AC; van Hillegersberg R; Elshof SM; de Weger RW; Borel Rinkes IH; van Diest PJ
    Eur J Surg Oncol; 2009 Oct; 35(10):1098-104. PubMed ID: 19304440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of gene expression profiling of pancreatic cancer.
    Goonetilleke KS; Siriwardena AK
    Int J Surg; 2008 Feb; 6(1):81-3. PubMed ID: 18359465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interobserver reproducibility of Her-2/neu protein overexpression in invasive breast carcinoma using the DAKO HercepTest.
    Hsu CY; Ho DM; Yang CF; Lai CR; Yu IT; Chiang H
    Am J Clin Pathol; 2002 Nov; 118(5):693-8. PubMed ID: 12428788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting and diagnosing ampullary neoplasms.
    Wang LF; Hingorani SR; Tuveson DA
    Cancer Biol Ther; 2004 Jul; 3(7):657-9. PubMed ID: 15326385
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunohistochemical study of mucins in chronic pancreatitis and ductal adenocarcinoma of the pancreas].
    Paklina OV; Setdikova GR
    Arkh Patol; 2008; 70(4):13-7. PubMed ID: 18807519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling identifies markers of ampullary adenocarcinoma.
    Van Heek NT; Maitra A; Koopmann J; Fedarko N; Jain A; Rahman A; Iacobuzio-Donahue CA; Adsay V; Ashfaq R; Yeo CJ; Cameron JL; Offerhaus JA; Hruban RH; Berg KD; Goggins M
    Cancer Biol Ther; 2004 Jul; 3(7):651-6. PubMed ID: 15136764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of the expression of HER-2/neu oncogene in ovarian lesions.
    Marwah N; Bansal C; Gupta S; Singh S; Sapna ; Arora B
    Indian J Pathol Microbiol; 2007 Jul; 50(3):489-92. PubMed ID: 17883115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential c-erbB-1 and c-erbB-2 mRNA expression in cancer of the pancreas compared with cancer of the papilla of Vater.
    Prenzel KL; Warnecke-Eberz U; Brabender J; Baldus SE; Bollschweiler E; Gutschow CA; Drebber U; Hoelscher AH; Schneider PM
    World J Gastroenterol; 2006 Jan; 12(3):437-42. PubMed ID: 16489645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER-2/neu analysis in breast cancer bone metastases.
    Zustin J; Boddin K; Tsourlakis MC; Burandt E; Mirlacher M; Jaenicke F; Izbicki J; Ruether W; Rueger JM; Bokemeyer C; Simon R; Sauter G
    J Clin Pathol; 2009 Jun; 62(6):542-6. PubMed ID: 19474354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Snapshots.
    Fine DR
    Pancreatology; 2014; 14(3):149-50. PubMed ID: 24854607
    [No Abstract]   [Full Text] [Related]  

  • 15. Small invasive ductal adenocarcinoma of the pancreas associated with lymphoplasmacytic sclerosing pancreatitis.
    Motosugi U; Ichikawa T; Yamaguchi H; Nakazawa T; Katoh R; Itakura J; Fujii H; Sato T; Araki T; Shimizu M
    Pathol Int; 2009 Oct; 59(10):744-7. PubMed ID: 19788620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic stellate cells and pancreatic carcinoma: an unholy alliance.
    Löhr JM; Jesnowski R
    JOP; 2009 Jul; 10(4):472-3. PubMed ID: 19581762
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship Between All-trans-13,14-Dihydro Retinoic Acid and Pancreatic Adenocarcinoma.
    Bazhin AV; Bleul T; de Lera AR; Werner J; Rühl R
    Pancreas; 2016 Jul; 45(6):e29-31. PubMed ID: 27295537
    [No Abstract]   [Full Text] [Related]  

  • 18. Proteomic and tissue array profiling identifies elevated hypoxia-regulated proteins in pancreatic ductal adenocarcinoma.
    Cui Y; Zhang D; Jia Q; Li T; Zhang W; Han J
    Cancer Invest; 2009 Aug; 27(7):747-55. PubMed ID: 19488907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel drug targets based on association between inflammation and pancreatic ductal adenocarcinoma.
    Saif MW
    JOP; 2010 Jul; 11(4):403-4; author reply 411. PubMed ID: 20601821
    [No Abstract]   [Full Text] [Related]  

  • 20. Pancreatic cancer development and progression: remodeling the model.
    Real FX; Cibrián-Uhalte E; Martinelli P
    Gastroenterology; 2008 Sep; 135(3):724-8. PubMed ID: 18692502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.